Aniridia is a devastating ocular disease requiring intensive eye care, social and community support from birth and throughout an individual’s lifetime.

Recent News

© 2019 Aniridia-net.eu – University of Cologne – Webdesign by Effect Group Ltd.

Aniridia-focused Symposium at the 2019 EVER Annual Congress held at Nice (France)

Aniridia-focused Symposium at the 2019 EVER Annual Congress held at Nice (France)

The European Association for Vision and Eye Research (EVER) Annual Congress held last October 2019 in Nice, France received a party of EU COST action ANIRIDIA-NET / #CA18116 members lead by Prof. Neil Lagali (Linköping University, Sweden) to present some of the recent European efforts to promote congenital aniridia research in a Special Interest Symposium. miRNA profiling of conjunctival cells (Lorenz Latta, University of Saarland), imaging of aniridia related abnormalities (Bogumil Wowra, University of Silesia), aniridia genotype-phenotype correlation (Dominique Bremond-Gignac, Necker University Hospital), novel keratoplasty techniques (Fabian Fries, University of Saarland), tear film cytokine profiling (Erlend Sommer Landsend, Oslo University Hospital), and animal modelling of aniridia-related keratopathy (Daniel Aberdam, INSERM-Paris) were some of the research highlights discussed in this aniridia-focused symposium.

No Comments

Post A Comment